XML 68 R40.htm IDEA: XBRL DOCUMENT
v3.19.2

Selected Quarterly Financial Data (Unaudited) (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2019
Quarterly Financial Information Disclosure [Abstract] |
Schedule of Selected Quarterly Financial Data | The following is selected quarterly financial data for fiscal 2019 and 2018. The sum of the quarters may not equal year-to-date due to rounding.
(in millions, except per common share amounts) | First Quarter (2) |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
Fiscal 2019 |  |  |  |  |  |  |
Revenue | $ | 35,213 |  |  | $ | 37,740 |  |  | $ | 35,228 |  |  | $ | 37,353 |
Gross margin (1) | 1,667 |  |  | 1,730 |  |  | 1,764 |  |  | 1,674 |
Distribution, selling, general and administrative expenses | 1,155 |  |  | 1,064 |  |  | 1,097 |  |  | 1,168 |
Net earnings | 594 |  |  | 281 |  |  | 296 |  |  | 194 |
Less: Net earnings attributable to noncontrolling interests | (1 | ) |  | (1 | ) |  | — |  |  | — |
Net earnings attributable to Cardinal Health, Inc. | 593 |  |  | 280 |  |  | 296 |  |  | 194 |
Net earnings attributable to Cardinal Health, Inc. per common share: |  |  |  |  |  |  |
Basic | $ | 1.95 |  |  | $ | 0.94 |  |  | $ | 0.99 |  |  | $ | 0.65 |
Diluted | 1.94 |  |  | 0.93 |  |  | 0.99 |  |  | 0.65 |
(1) | Gross margin was not impacted by LIFO benefit/(charges) in fiscal 2019.
(2) | Includes a $508 million gain ($378 million after-tax) related to the naviHealth divestiture.
(in millions, except per common share amounts) | First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
Fiscal 2018 |  |  |  |  |  |  |
Revenue | $ | 32,641 |  |  | $ | 35,186 |  |  | $ | 33,633 |  |  | $ | 35,349 |
Gross margin (1) | 1,672 |  |  | 1,861 |  |  | 1,913 |  |  | 1,735 |
Distribution, selling, general and administrative expenses | 1,062 |  |  | 1,131 |  |  | 1,132 |  |  | 1,270 |
Net earnings/(loss) (2) | 117 |  |  | 1,053 |  |  | 255 |  |  | (1,166 | )
Less: Net earnings attributable to noncontrolling interests | (2 | ) |  | — |  |  | — |  |  | — |
Net earnings/(loss) attributable to Cardinal Health, Inc. | 115 |  |  | 1,053 |  |  | 255 |  |  | (1,166 | )
Net earnings/(loss) attributable to Cardinal Health, Inc. per common share: |  |  |  |  |  |  |
Basic | $ | 0.36 |  |  | $ | 3.35 |  |  | $ | 0.81 |  |  | $ | (3.76 | )
Diluted (3) | 0.36 |  |  | 3.33 |  |  | 0.81 |  |  | (3.76 | )
(1) | Gross margin was not impacted by LIFO benefit/(charges) in fiscal 2018.
(2) | During the fourth quarter of fiscal 2018, we recognized a goodwill impairment charge of $1.4 billion related to our Medical segment. There was no tax benefit related to this goodwill impairment charge.
(3) | Due to the net loss during the fourth quarter of fiscal 2018, dilutive potential common shares have not been included in the denominator of the dilutive per share computation due to their antidilutive effect.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=118952077&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration